Crossject SA (ALCJ FP)

Analysis

Health Care • France

Crossject SA develops needle-free injection systems for liquid medicines. The Company product ZENEO is tailored to deliver drugs intra-dermally, subcutaneously and intramuscularly.

Refresh

Focused

No publications yet

There aren’t any Insights right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00